In patients with early-stage ovarian cancer, a high prognostic nutritional index improved survival, while a high systemic immune-inflammation index worsened it. In advanced stages, both affected ...

Company successfully identified several abandoned or discontinued drugs for further testing and development in ovarian and ...

Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer today announced that it, along with its partner Moffitt ...

Company successfully identified several abandoned or discontinued drugs for further testing and development in ovarian and other cancer types Creates significant business development opportunities wit ...

Predictive Oncology stock is trading higher on Tuesday after the company reported positive results from utilizing artificial intelligence for drug repurposing.

Amendment expands the potential benefits of CAR-T therapy allowing a second dose and includes more ovarian cancer histologies SAN JOSE, Calif., Feb. 18, 2025 /PRNewswire/ ...

Compugen's innovative approach targets under-explored immune pathways like PVRIG and IL-18 binding protein. Read why I'm ...

We recently published a list of Top 10 Trending AI News On Wall Street’s Radar. In this article, we are going to take a look at where Predictive Oncology Inc. (NASDAQ:POAI) stands against other top ...

After Teddi Mellencamp underwent emergency brain surgery for her tumors, the Real Housewives of Beverly Hills star’s sister Justice Mellencamp shared an update on her recovery.

More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.

As the DeepSeek-driven sell-off in US AI stocks started to fade, China is claiming advances in another new-age technology ...

Stock analysts at HC Wainwright dropped their FY2024 earnings per share estimates for SpringWorks Therapeutics in a research note issued on Wednesday, February 12th. HC Wainwright analyst R. Burns now ...